High incidence of typhoid fever in sub-Saharan Africa necessitates typhoid conjugate vaccines (TCVs).
Researchers part of the Severe Typhoid in Africa study enrolled patients with fever or reported fever for 3 consecutive days within the previous 7 days. Typhoid fever was confirmed by isolating Salmonella enterica serovar Typhi from blood cultures.
Burkina Faso, the DRC, Ghana, and Madagascar had an adjusted typhoid incidence of over 100 cases per 100,000 person-years, with the highest in the DRC (315 cases).
Rural settings reported the highest incidence, however, the introduction of TCVs could substantially contribute to typhoid fever control efforts.